Clinical trial
A Randomized, Open Label, Long-Term, Multi-Center Study of the Safety of Medisorb® Naltrexone
NCT01218997 is registered in ClinicalTrials.gov with Alkermes, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open Label, Long-Term, Multi-Center Study of the Safety of Medisorb® Naltrexone
- Lead sponsor
- Alkermes, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2003
- Completion date
- March 31, 2005
- Enrollment
- 436 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.